An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
Lysophosphatidylcholine (LPC) is increasingly recognized as a key marker/factor positively associated with cardiovascular and neurodegenerative diseases. However, findings from recent clinical lipidomic studies of LPC have been controversial. A key issue is the complexity of the enzymatic cascade in...
Main Authors: | Shi-Hui Law, Mei-Lin Chan, Gopal K. Marathe, Farzana Parveen, Chu-Huang Chen, Liang-Yin Ke |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/20/5/1149 |
Similar Items
-
An Updated Review of Pro- and Anti-Inflammatory Properties of Plasma Lysophosphatidylcholines in the Vascular System
by: Eva Knuplez, et al.
Published: (2020-06-01) -
Arabidopsis cytosolic acyl‐CoA‐binding proteins function in determining seed oil composition
by: Ze‐Hua Guo, et al.
Published: (2019-12-01) -
Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages
by: Antonio Gómez-Muñoz, et al.
Published: (1999-06-01) -
Role of Group 1B Phospholipase A2 in Diet-induced Hyperlipidemia and Selected Disorders of Lipid Metabolism
by: Hollie, Norris I., II
Published: (2013) -
Berberine Suppresses Colonic Inflammation in Dextran Sulfate Sodium–Induced Murine Colitis Through Inhibition of Cytosolic Phospholipase A2 Activity
by: Lixiang Zhai, et al.
Published: (2020-11-01)